QYR Market Research USA UV Infection Control Device market research | Page 6

QYResearch
In addition to the human toll, hospitals now have a financial reason to
reduce hospital-acquired infections: beginning in 2017, the federal
government will dramatically reduce Medicare payments to hospitals that
exceed incidences of them and of other conditions.
Significant and lasting barriers make entry into this market difficult.
These barriers include, but are not limited to: (i) product development
costs; (ii) capital requirements; (iii) intellectual property rights; (iv)
regulatory requirement; and (v) Transitions’ unfair methods of competition.
www.qyresearch.com
www.qyresearch.com